TY - JOUR
T1 - ABCG2 Mediates Resistance to the Dual EGFR and PI3K Inhibitor MTX-211 in Cancer Cells
AU - Wu, Chung Pu
AU - Hung, Cheng Yu
AU - Murakami, Megumi
AU - Wu, Yu Shan
AU - Chu, Yi Hsuan
AU - Huang, Yang Hui
AU - Yu, Jau Song
AU - Ambudkar, Suresh V.
N1 - Publisher Copyright:
© 2024 by the authors.
PY - 2024/5/9
Y1 - 2024/5/9
N2 - MTX-211 is a first-in-class dual inhibitor of epidermal growth factor receptor (EGFR) and phosphoinositide-3 kinase (PI3K) signaling pathways with a compelling pharmaceutical profile and could enhance the effectiveness of mitogen-activated protein kinase kinase (MEK) inhibitor therapy in colorectal tumors with KRAS mutations. However, the specific mechanisms contributing to the acquired resistance to MTX-211 in human cancers remain elusive. Here, we discovered that the overexpression of the ATP-binding cassette (ABC) drug transporter ABCG2, a prevalent mechanism associated with multidrug resistance (MDR), could diminish the effectiveness of MTX-211 in human cancer cells. We showed that the drug efflux activity of ABCG2 substantially decreased the intracellular accumulation of MTX-211 in cancer cells. As a result, the cytotoxicity and effectiveness of MTX-211 in suppressing the activation of the EGFR and PI3K pathways were significantly attenuated in cancer cells overexpressing ABCG2. Moreover, the enhancement of the MTX-211-stimulated ATPase activity of ABCG2 and the computational molecular docking analysis illustrating the binding of MTX-211 to the substrate-binding sites of ABCG2 offered a further indication for the interaction between MTX-211 and ABCG2. In summary, our findings indicate that MTX-211 acts as a substrate for ABCG2, underscoring the involvement of ABCG2 in the emergence of resistance to MTX-211. This finding carries clinical implications and merits further exploration.
AB - MTX-211 is a first-in-class dual inhibitor of epidermal growth factor receptor (EGFR) and phosphoinositide-3 kinase (PI3K) signaling pathways with a compelling pharmaceutical profile and could enhance the effectiveness of mitogen-activated protein kinase kinase (MEK) inhibitor therapy in colorectal tumors with KRAS mutations. However, the specific mechanisms contributing to the acquired resistance to MTX-211 in human cancers remain elusive. Here, we discovered that the overexpression of the ATP-binding cassette (ABC) drug transporter ABCG2, a prevalent mechanism associated with multidrug resistance (MDR), could diminish the effectiveness of MTX-211 in human cancer cells. We showed that the drug efflux activity of ABCG2 substantially decreased the intracellular accumulation of MTX-211 in cancer cells. As a result, the cytotoxicity and effectiveness of MTX-211 in suppressing the activation of the EGFR and PI3K pathways were significantly attenuated in cancer cells overexpressing ABCG2. Moreover, the enhancement of the MTX-211-stimulated ATPase activity of ABCG2 and the computational molecular docking analysis illustrating the binding of MTX-211 to the substrate-binding sites of ABCG2 offered a further indication for the interaction between MTX-211 and ABCG2. In summary, our findings indicate that MTX-211 acts as a substrate for ABCG2, underscoring the involvement of ABCG2 in the emergence of resistance to MTX-211. This finding carries clinical implications and merits further exploration.
KW - ABCG2
KW - EGFR
KW - MTX-211
KW - multidrug resistance
KW - PI3K
KW - Phosphoinositide-3 Kinase Inhibitors/pharmacology
KW - Humans
KW - Phosphatidylinositol 3-Kinases/metabolism
KW - Neoplasms/drug therapy
KW - Signal Transduction/drug effects
KW - Antineoplastic Agents/pharmacology
KW - Drug Resistance, Neoplasm/genetics
KW - Neoplasm Proteins/genetics
KW - Cell Line, Tumor
KW - ATP Binding Cassette Transporter, Subfamily G, Member 2/metabolism
KW - Molecular Docking Simulation
KW - Protein Kinase Inhibitors/pharmacology
KW - ErbB Receptors/metabolism
UR - https://www.scopus.com/pages/publications/85194218977
U2 - 10.3390/ijms25105160
DO - 10.3390/ijms25105160
M3 - 文章
C2 - 38791198
SN - 1661-6596
VL - 25
JO - International Journal of Molecular Sciences
JF - International Journal of Molecular Sciences
IS - 10
M1 - 5160
ER -